Minimally invasive options in dupuytren's contracture: Aponeurotomy, enzymes, stretching, and fat grafting

Plastic and Reconstructive Surgery

Volumn 134, Issue 5, 2014, Pages 822e-829e

  Murphy, Amanda ^a   Lalonde, Donald H ^a   Eaton, Charles ^a   Denkler, Keith ^a   Hovius, Steven E R ^a   Smith, Anthony A ^a   Martin, Alison ^a   Biswas, Atanu ^a   Van Nieuwenhoven, C ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE;

ADIPOSE TISSUE; DUPUYTREN CONTRACTURE; FASCIA; FEMALE; FOLLOW UP; HUMAN; KINESIOTHERAPY; MALE; ORTHOPEDIC SURGERY; PROCEDURES; STRETCHING EXERCISE; SURGERY; TISSUE TRANSPLANTATION; TRANSPLANTATION; TREATMENT OUTCOME;

ADIPOSE TISSUE; COLLAGENASES; DUPUYTREN CONTRACTURE; EXERCISE THERAPY; FASCIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MUSCLE STRETCHING EXERCISES; ORTHOPEDIC PROCEDURES; TISSUE TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84925027193     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000603     Document Type: Article

References (40)

1. Lermusiaux JL, Debeyre N. Le traitement medical de la maladie de Dupuytren. In: de Seze S, Ryckewaert A, Kahn MF, Guerin CI, eds. L'actualite rhumatologique 1979. Paris: Expansion Scientifique Francaise; 1980:338-343.
2. Eaton C. Percutaneous fasciotomy for Dupuytren's contracture. J Hand Surg Am. 2011;36:910-915.
3. van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: Percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129:469-477.
4. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: A 6-week follow-up study. J Hand Surg Am. 2006;31:717-725.
5. McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren contracture: A randomized, controlled study. J Hand Surg Am. 2012;37:1307-1312.
6. Kan HJ, Verrijp FW, Huisstede BM, Hovius SE, van Nieuwenhoven CA, Selles RW. The consequences of different definitions for recurrence of Dupuytren's disease. J Plast Reconstr Aesthet Surg. 2013;66:95-103.
7. Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: The importance of clear definitions. J Hand Surg Am. 2012;37:2095-2105.e7.
8. Larocerie-Salgado J, Davidson J. Nonoperative treatment of PIPJ flexion contractures associated with Dupuytren's disease. J Hand Surg Eur Vol.2012;37:722-727.
9. Hurst LC, Badalamente MA, Hentz VR, et al.; CORD I Study Group. Injectable collagenase C. histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968-979.
10. Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase C. histolyticum: A new nonsurgical treatment for Dupuytren's disease. J Hand Surg Am. 2010;35:2027-2038.e1.
11. Hovius SE, Kan HJ, Smit X, Selles RW, Cardoso E, Khouri RK. Extensive percutaneous aponeurotomy and lipografting: A new treatment for Dupuytren disease. Plast Reconstr Surg. 2011;128:221-228.
12. Schultz I, Lindegren A, Wickman M. Improved shape and consistency after lipofilling of the breast: Patients' evaluation of the outcome. J Plast Surg Hand Surg. 2012;46:85-90.
13. Dominguez-Malagon HR, Alfeiran-Ruiz A, Chavarria- Xicotencatl P, Duran-Hernandez MS. Clinical and cellular effects of colchicine in fibromatosis. Cancer 1992;69:2478-2483.
14. Murrell GA, Francis MJ, Bromley L. Free radicals and Dupuytren's contracture. BMJ (Clin Res Ed.) 1987;295: 1373-1375.
15. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000;25:1157-1162.
16. Rayan GM, Parizi M, Tomasek JJ. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro. J Hand Surg Am. 1996;21:1065-1070.
17. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767-774.
18. Chiu HF, McFarlane RM. Pathogenesis of Dupuytren's contracture: A correlative clinical-pathological study. J Hand Surg Am. 1978;3:1-10.
19. Luck JV. Dupuytren's contracture: A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am. 1959;41:635-664.
20. Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R,Adams JP. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am. 1981;63:787-797.
21. Mookhtiar KA, Van Wart HE. C. histolyticum collagenases: A new look at some old enzymes. Matrix Suppl. 1992;1:116-126.
22. Matsushita O, Okabe A. Clostridial hydrolytic enzymes degrading extracellular components. Toxicon 2001;39:1769-1780.
23. Mallya SK, Mookhtiar KA, Van Wart HE. Kinetics of hydrolysis of type I, II, and III collagens by the class I and II C. histolyticum collagenases. J Protein Chem. 1992;11:99-107.
24. French MF, Bhown A, Van Wart HE. Identification of C. histolyticum collagenase hyperreactive sites in type I, II, and III collagens: Lack of correlation with local triple helical stability. J Protein Chem. 1992;11:83-97.
25. Van Wart HE, Steinbrink DR. Complementary substrate specificities of class I and class II collagenases from C. histolyticum. Biochemistry 1985;24:6520-6526.
26. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am. 2007;32:767-774.
27. Miyoshi S, Nakazawa H, Kawata K, Tomochika K, Tobe K, Shinoda S. Characterization of the hemorrhagic reaction caused by Vibrio vulnificus metalloprotease, a member of the thermolysin family. Infect Immun. 1998;66:4851-4855.
28. Trüeb B, Bornstein P. Characterization of the precursor form of type VI collagen. J Biol Chem. 1984;259:8597-8604.
29. Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000;25:629-636.
30. Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: Nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002;27:788-798.
31. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg Am. 2010;35:534-539, 539.e1.
32. Witthaut J, Jones G, Skrepnik N, Kushner H, Houston A, Lindau TR. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: Shortterm results from 2 open-label studies. J Hand Surg Am. 2013;38:2-11.
33. Peimer CA, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase C. histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013;38:12-22.
34. Auxilium Pharmaceuticals, Inc. Auxilium Pharmaceuticals, Inc. announces 30 month Xiaflex safety update. Available at: http://ir.auxilium.com/phoenix.zhtml?c=142125&p=irolnews. Accessed April 12, 2012.
35. Agee JM, Goss BC. The use of skeletal extension torque in reversing Dupuytren contractures of the proximal interphalangeal joint. J Hand Surg Am. 2012;37:1467-1474.
36. Craft RO, Smith AA, Coakley B, Casey WJ III, Rebecca AM, Duncan SF. Checkrein ligament release after fasciectomy in the treatment of Dupuytren proximal interphalangeal joint contractures. Plast Reconstr Surg. 2011;128: 1107-1113.
37. Larocerie-Salgado J, Davidson J. Nonoperative treatment of PIPJ flexion contractures associated with Dupuytren's disease. J Hand Surg Eur Vol.2012;37:722-727.
38. Christie WS, Puhl AA, Lucaciu OC. Cross-frictional therapy and stretching for the treatment of palmar adhesions due to Dupuytren's contracture: A prospective case study. Man Ther. 2012;17:479-482.
39. Chen N, Srinivasan R, Shauver M, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand. 2011;6:250-255.
40. Chen N, Shauver M, Chung KC. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg Am. 2001;36:1826-1834.